Lower melting pharmaceutical cocrystals of metaxalone with carboxamide functionalities

Sunil Kumar V. Gohel, Palash Sanphui, Girij Pal Singh, Krishnamurthy Bhat, Muthuramalingam Prakash

Research output: Contribution to journalArticle

Abstract

Supramolecular reactions between a muscle relaxant drug, Metaxalone, 5-[(3,5-dimethylphenoxy)methyl]-2-oxazolidinone with a few carboxamides like nicotinamide, isonicotinamide, salicylamide and carboxylic acid coformers such as 3-hydroxybenzoic acid, 4-hydroxybenzoic acid resulted binary cocrystals. The cocrystals were initially characterized by PXRD, FT˗IR, ss-NMR, DSC and finally confirmed by single crystal X-ray diffraction. Surprisingly, all the novel cocrystals exhibited melting endotherm lower than the drug and coformer, which is not so common (29%) in the literature. Vibrational spectroscopy suggests the possible stoichiometry of the drug cocrystals based on the number of carbonyl stretching frequencies and hydrate formation in case of 4-hydroxybenzoic acid cocrystal. 13C-ssNMR spectroscopy of metaxalone–salicylamide cocrystal indicates the possibility of more symmetry independent molecule of the drug in the starting material to less in the cocrystal and molecular conformation was also reflected in the spectrum. The corresponding crystal structure consists of one molecule each of metaxalone and salicylamide in the asymmetric unit. Similar to the thermodynamically stable form of the drug and cocrystals with mono/di-carboxylic acids, metaxalone forms centrosymmetric N–H⋯O hydrogen bonded imide-imide homodimer in this cocrystal. Salicylamide molecules also form centrosymmetric amide-amide homosynthon. Both the homodimers are perpendicularly (79°) interlinked via bifurcated carbonyl oxygen of the drug, which results 1D chain along the crystallographic b-axis. Auxiliary C˗H⋯O interactions further stabilize the bonding between the drug and salicylamide. Binding energy calculation of metaxalone/salicylamide homodimer and metaxalone‒salicylamide heterodimer using B3LYP/6-311++G** method and in addition, the stacking energy interactions in the API suggest the most preferred API homodimer synthon in the reported polymorphs and cocrystals. The pharmaceutical cocrystals of metaxalone with amide functionalities are reported for the first time in the literature.

Original languageEnglish
Pages (from-to)479-490
Number of pages12
JournalJournal of Molecular Structure
Volume1178
DOIs
Publication statusPublished - 15-02-2019

Fingerprint

Melting
Pharmaceutical Preparations
Amides
Imides
Carboxylic Acids
Application programming interfaces (API)
Molecules
Vibrational spectroscopy
Niacinamide
metaxalone
Hydrates
Polymorphism
Binding energy
Stoichiometry
Stretching
Muscle
Conformations
Hydrogen
Crystal structure
Nuclear magnetic resonance

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Spectroscopy
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Gohel, Sunil Kumar V. ; Sanphui, Palash ; Singh, Girij Pal ; Bhat, Krishnamurthy ; Prakash, Muthuramalingam. / Lower melting pharmaceutical cocrystals of metaxalone with carboxamide functionalities. In: Journal of Molecular Structure. 2019 ; Vol. 1178. pp. 479-490.
@article{0ad5eb3ad31f4b45b64f02f2cbcd112d,
title = "Lower melting pharmaceutical cocrystals of metaxalone with carboxamide functionalities",
abstract = "Supramolecular reactions between a muscle relaxant drug, Metaxalone, 5-[(3,5-dimethylphenoxy)methyl]-2-oxazolidinone with a few carboxamides like nicotinamide, isonicotinamide, salicylamide and carboxylic acid coformers such as 3-hydroxybenzoic acid, 4-hydroxybenzoic acid resulted binary cocrystals. The cocrystals were initially characterized by PXRD, FT˗IR, ss-NMR, DSC and finally confirmed by single crystal X-ray diffraction. Surprisingly, all the novel cocrystals exhibited melting endotherm lower than the drug and coformer, which is not so common (29{\%}) in the literature. Vibrational spectroscopy suggests the possible stoichiometry of the drug cocrystals based on the number of carbonyl stretching frequencies and hydrate formation in case of 4-hydroxybenzoic acid cocrystal. 13C-ssNMR spectroscopy of metaxalone–salicylamide cocrystal indicates the possibility of more symmetry independent molecule of the drug in the starting material to less in the cocrystal and molecular conformation was also reflected in the spectrum. The corresponding crystal structure consists of one molecule each of metaxalone and salicylamide in the asymmetric unit. Similar to the thermodynamically stable form of the drug and cocrystals with mono/di-carboxylic acids, metaxalone forms centrosymmetric N–H⋯O hydrogen bonded imide-imide homodimer in this cocrystal. Salicylamide molecules also form centrosymmetric amide-amide homosynthon. Both the homodimers are perpendicularly (79°) interlinked via bifurcated carbonyl oxygen of the drug, which results 1D chain along the crystallographic b-axis. Auxiliary C˗H⋯O interactions further stabilize the bonding between the drug and salicylamide. Binding energy calculation of metaxalone/salicylamide homodimer and metaxalone‒salicylamide heterodimer using B3LYP/6-311++G** method and in addition, the stacking energy interactions in the API suggest the most preferred API homodimer synthon in the reported polymorphs and cocrystals. The pharmaceutical cocrystals of metaxalone with amide functionalities are reported for the first time in the literature.",
author = "Gohel, {Sunil Kumar V.} and Palash Sanphui and Singh, {Girij Pal} and Krishnamurthy Bhat and Muthuramalingam Prakash",
year = "2019",
month = "2",
day = "15",
doi = "10.1016/j.molstruc.2018.10.039",
language = "English",
volume = "1178",
pages = "479--490",
journal = "Journal of Molecular Structure",
issn = "0022-2860",
publisher = "Elsevier",

}

Lower melting pharmaceutical cocrystals of metaxalone with carboxamide functionalities. / Gohel, Sunil Kumar V.; Sanphui, Palash; Singh, Girij Pal; Bhat, Krishnamurthy; Prakash, Muthuramalingam.

In: Journal of Molecular Structure, Vol. 1178, 15.02.2019, p. 479-490.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lower melting pharmaceutical cocrystals of metaxalone with carboxamide functionalities

AU - Gohel, Sunil Kumar V.

AU - Sanphui, Palash

AU - Singh, Girij Pal

AU - Bhat, Krishnamurthy

AU - Prakash, Muthuramalingam

PY - 2019/2/15

Y1 - 2019/2/15

N2 - Supramolecular reactions between a muscle relaxant drug, Metaxalone, 5-[(3,5-dimethylphenoxy)methyl]-2-oxazolidinone with a few carboxamides like nicotinamide, isonicotinamide, salicylamide and carboxylic acid coformers such as 3-hydroxybenzoic acid, 4-hydroxybenzoic acid resulted binary cocrystals. The cocrystals were initially characterized by PXRD, FT˗IR, ss-NMR, DSC and finally confirmed by single crystal X-ray diffraction. Surprisingly, all the novel cocrystals exhibited melting endotherm lower than the drug and coformer, which is not so common (29%) in the literature. Vibrational spectroscopy suggests the possible stoichiometry of the drug cocrystals based on the number of carbonyl stretching frequencies and hydrate formation in case of 4-hydroxybenzoic acid cocrystal. 13C-ssNMR spectroscopy of metaxalone–salicylamide cocrystal indicates the possibility of more symmetry independent molecule of the drug in the starting material to less in the cocrystal and molecular conformation was also reflected in the spectrum. The corresponding crystal structure consists of one molecule each of metaxalone and salicylamide in the asymmetric unit. Similar to the thermodynamically stable form of the drug and cocrystals with mono/di-carboxylic acids, metaxalone forms centrosymmetric N–H⋯O hydrogen bonded imide-imide homodimer in this cocrystal. Salicylamide molecules also form centrosymmetric amide-amide homosynthon. Both the homodimers are perpendicularly (79°) interlinked via bifurcated carbonyl oxygen of the drug, which results 1D chain along the crystallographic b-axis. Auxiliary C˗H⋯O interactions further stabilize the bonding between the drug and salicylamide. Binding energy calculation of metaxalone/salicylamide homodimer and metaxalone‒salicylamide heterodimer using B3LYP/6-311++G** method and in addition, the stacking energy interactions in the API suggest the most preferred API homodimer synthon in the reported polymorphs and cocrystals. The pharmaceutical cocrystals of metaxalone with amide functionalities are reported for the first time in the literature.

AB - Supramolecular reactions between a muscle relaxant drug, Metaxalone, 5-[(3,5-dimethylphenoxy)methyl]-2-oxazolidinone with a few carboxamides like nicotinamide, isonicotinamide, salicylamide and carboxylic acid coformers such as 3-hydroxybenzoic acid, 4-hydroxybenzoic acid resulted binary cocrystals. The cocrystals were initially characterized by PXRD, FT˗IR, ss-NMR, DSC and finally confirmed by single crystal X-ray diffraction. Surprisingly, all the novel cocrystals exhibited melting endotherm lower than the drug and coformer, which is not so common (29%) in the literature. Vibrational spectroscopy suggests the possible stoichiometry of the drug cocrystals based on the number of carbonyl stretching frequencies and hydrate formation in case of 4-hydroxybenzoic acid cocrystal. 13C-ssNMR spectroscopy of metaxalone–salicylamide cocrystal indicates the possibility of more symmetry independent molecule of the drug in the starting material to less in the cocrystal and molecular conformation was also reflected in the spectrum. The corresponding crystal structure consists of one molecule each of metaxalone and salicylamide in the asymmetric unit. Similar to the thermodynamically stable form of the drug and cocrystals with mono/di-carboxylic acids, metaxalone forms centrosymmetric N–H⋯O hydrogen bonded imide-imide homodimer in this cocrystal. Salicylamide molecules also form centrosymmetric amide-amide homosynthon. Both the homodimers are perpendicularly (79°) interlinked via bifurcated carbonyl oxygen of the drug, which results 1D chain along the crystallographic b-axis. Auxiliary C˗H⋯O interactions further stabilize the bonding between the drug and salicylamide. Binding energy calculation of metaxalone/salicylamide homodimer and metaxalone‒salicylamide heterodimer using B3LYP/6-311++G** method and in addition, the stacking energy interactions in the API suggest the most preferred API homodimer synthon in the reported polymorphs and cocrystals. The pharmaceutical cocrystals of metaxalone with amide functionalities are reported for the first time in the literature.

UR - http://www.scopus.com/inward/record.url?scp=85056196498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056196498&partnerID=8YFLogxK

U2 - 10.1016/j.molstruc.2018.10.039

DO - 10.1016/j.molstruc.2018.10.039

M3 - Article

VL - 1178

SP - 479

EP - 490

JO - Journal of Molecular Structure

JF - Journal of Molecular Structure

SN - 0022-2860

ER -